Wegovy becomes first GLP-1RA to gain FDA MASH approval
Danish big pharma Novo Nordisk has been given the go-ahead for its star weight loss drug, Wegovy (semaglutide), in patients…
All articles by Annabel Kartal Allen
Annabel Kartal Allen
-
-
Sanofi’s Tzield secures MHRA go-ahead for type 1 diabetes
Sanofi-owned Aventis Pharma has received approval for its type 1 diabetes (T1D) drug, Tzield (teplizumab), from the UK Medicines and…
-
UK chikungunya cases rise amid vaccine safety concerns
New data published by the UK Health Security Agency (UKHSA) has found that travel-related chikungunya cases are up 170%, as…
-
PureTech forms respiratory spin-off Celea to advance deuterated pirfenidone
US-based PureTech Health has launched Celea Therapeutics, a new respiratory disease-focused biotherapeutics spin-off, to make efficient use of its capital.…
-
Third time lucky as PharmaTher gets FDA approval for ketamine
Canada-based PharmaTher has received US Food and Drug Administration (FDA) approval for its ketamine therapy for surgical pain management, KETARx…
-
Boehringer’s Hernexeos receives fast-tracked FDA approval
Boehringer Ingelheim has received fast-track approval from the US Food and Drug Administration (FDA) for its targeted therapy, Hernexeos (zongertinib…
-
Gilead’s Yeztugo sales “ahead of expectations” following launch
After Gilead Sciences was given the green light for Yeztugo (lenacapavir) in the US and Europe, CCO Johanna Mercier said…
-
RFK Jr’s mRNA funding halt signals “shift in US public health”
Robert F Kennedy, Jr (RFK Jr) has announced plans to cut government funding to messenger RNA (mRNA) vaccine development run…
-
US-China tensions offer new opportunity for APAC biotechs, report suggests
Investors are increasingly focused on biotech companies outside of China operating in the Asia-Pacific (APAC) market, according to a report…
-
Sandoz bolsters in-house biosimilar manufacturing with Evotec acquisition
In a bid to boost its presence in the lucrative biosimilar space, Sandoz has signed a non-binding agreement to buy…